Profil
Jason Barker served as Managing Director at Bauer York LLC from 2011 to 2015.
Prior to that, he was the Chief Accounting Officer & Head-Finance at ARYx Therapeutics, Inc. from 2009 to 2011.
He also served as the Chief Financial Officer at Zosano Pharma Corp.
Additionally, he briefly served as the Chief Financial Officer at Astellas Gene Therapies, Inc. in 2015.
In 2019, he became the VP, Chief Financial & Accounting Officer at Arcus Biosciences, Inc. Barker received his undergraduate degree from The University of Texas at Austin.
Anciens postes connus de Jason Barker
| Sociétés | Poste | Fin |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Directeur Financier/CFO | 01/08/2020 |
| AUDENTES THERAPEUTICS, INC. | Directeur Financier/CFO | 29/09/2015 |
Bauer York LLC | Corporate Officer/Principal | 01/01/2015 |
| ARYX THERAPEUTICS, INC. | Directeur Financier/CFO | 09/07/2009 |
| ZOSANO PHARMA CORPORATION | Directeur Financier/CFO | - |
Formation de Jason Barker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
ARYx Therapeutics, Inc.
ARYx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zosano Pharma Corp.
Zosano Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that specializes in the systemic administration of therapeutics | Health Technology |
Astellas Gene Therapies, Inc.
Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
Arcus Biosciences, Inc.
Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Bauer York LLC |
















